Semaglutide Reduces BMI Category for Adolescents With Obesity
Improvement of one or more BMI category seen for majority of participants receiving semaglutide.
Improvement of one or more BMI category seen for majority of participants receiving semaglutide.
Afternoon exercise group had greatest reduction in HbA1c at year 1 among adults with overweight or obesity and type 2 diabetes.
The FDA does not review compounded drugs for safety, effectiveness, or quality; compounded medications are not FDA-approved
Expert discusses identifying and managing nutrient deficiencies or eating habits that can contribute to mental health conditions including depression and anxiety
Odds of infection, venous thromboembolism, renal complications increased for patients with overweight, obesity.
Wegovy is a glucagon-like peptide-1 receptor agonist.
Tirzepatide is a once-weekly, dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist.
Researchers analyzed the relationship between dietary choline and betaine intake and serum lipids, blood pressure, and glycemic markers among individuals with obesity.
Dr Zhaoping Li discusses 2 ongoing studies investigating the use of precision nutrition for personalized weight loss plans.
The findings contribute to the understanding of neurological factors driving the sex-specific pathophysiology of obesity.